Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Exenatide
(D04121)		[1] Exenatide[1] Exenatide (D04121) 💬[1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[6] 6, 17, 72, 78, 193, 233 💬
2Exenatide 10 micrograms
(D04121)		[1] Exenatide[1] Exenatide (D04121) 💬[1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 6 💬
3Exenatide 5 micrograms
(D04121)		[1] Exenatide[1] Exenatide (D04121) 💬[1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 6 💬
4Exenatide extended release 2mg (Bydureon)
(D04121)		[1] Exenatide[1] Exenatide (D04121) 💬[1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 6 💬
5Exenatide Pen Injector [Bydureon]
(D04121)		[1] Exenatide[1] Exenatide (D04121) 💬[1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 17 💬
6Experimental: GLP1-RA (exenatide) administration
(D04121)		[1] Exenatide[1] Exenatide (D04121) 💬[1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 72, 78 💬